On the morning of September 9, Chi Fulin, president of the China (Hainan) Reform and Development Research Institute, visited Neogene to investigate the progress in the field of anti-drug and provide guidance for future development.

At the beginning of 2017, Neogene was jointly initiated by China (Hainan) Reform and Development Research Institute. Since its establishment, Neogene has been guided by the service of public security and anti-drug work, with advanced hair drug detection technology as the entry point, and gradually established an industrial ecosystem of drug testing, judicial identification, sewage drug monitoring, and non-invasive drug rehabilitation technology. Dr. Zhu Xiaojin, General Manager of Neogene, gave a detailed introduction to the development and planning of the company's four business segments. Dean Sue affirmed the results of the work achieved by Neogene.

In response to the next development strategy of Neogene, the late director proposed important opinions such as strengthening the construction of scientific research, focusing on breaking through core technical barriers, and improving the construction of the talent system, and placed high hopes on the future development of the company.